BELVEDERESI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 487
EU - Europa 290
AS - Asia 94
SA - Sud America 25
AF - Africa 18
Totale 914
Nazione #
US - Stati Uniti d'America 487
IT - Italia 76
UA - Ucraina 46
IE - Irlanda 33
SE - Svezia 33
SG - Singapore 30
RU - Federazione Russa 27
BR - Brasile 23
DE - Germania 20
CN - Cina 18
HK - Hong Kong 18
DK - Danimarca 17
TR - Turchia 12
CI - Costa d'Avorio 10
FI - Finlandia 10
FR - Francia 10
KR - Corea 9
MA - Marocco 8
GB - Regno Unito 7
BE - Belgio 4
NL - Olanda 3
AR - Argentina 2
AT - Austria 2
HR - Croazia 1
IL - Israele 1
IN - India 1
KG - Kirghizistan 1
LT - Lituania 1
PH - Filippine 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 914
Città #
Chandler 94
Jacksonville 49
Ashburn 40
Dublin 33
Boardman 31
New York 30
Fairfield 29
Ancona 20
Singapore 20
Hong Kong 18
Woodbridge 18
Wilmington 16
Houston 15
Ann Arbor 14
Lawrence 11
Princeton 11
Abidjan 10
San Mateo 10
Turin 9
Cambridge 8
Centro 7
Cagliari 6
San Diego 6
Seattle 5
The Dalles 5
Des Moines 4
Moscow 4
Amsterdam 3
Beijing 3
Brussels 3
Falconara Marittima 3
Los Angeles 3
São Paulo 3
Washington 3
Arzano 2
Helsinki 2
London 2
Roseto degli Abruzzi 2
Vienna 2
Altidona 1
Aparecida de Goiânia 1
Araucária 1
Belo Horizonte 1
Bishkek 1
Blumenau 1
Capelinha 1
Carmona 1
Chengdu 1
Clifton 1
Dong Ket 1
Dushanbe 1
Empalme San Vicente 1
Esplanada 1
Fortaleza 1
Goiânia 1
Guangzhou 1
Guanhães 1
Guarulhos 1
Hortolândia 1
Ipatinga 1
Jiaxing 1
Joinville 1
Los Altos 1
Manaus 1
Marília 1
Mauá 1
Morro do Chapéu 1
Munich 1
New Bedfont 1
Phoenix 1
Piedade 1
Prescot 1
Rio de Janeiro 1
San Francisco 1
Shanghai 1
Stockholm 1
São Gabriel 1
Tashkent 1
Tekirdağ 1
Tel Aviv 1
Turku 1
Waterloo 1
Wuhan 1
Wuhu 1
Wuxi 1
Zibo 1
Totale 601
Nome #
An intronic mutation in MLH1 associated with familial colon and breast cancer. 102
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: Are all mutations equal? 94
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 94
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 93
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 86
Therapeutic Challenges in Tissue Engineering 80
MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system 74
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 72
Mutazioni nei geni del MMR e sindrome HNPCC: analisi in vitro della patogenicità delle varianti missenso 68
Expectations and psychological issues before genetic counseling: analysis of distress determinant factors 68
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 60
BRCA mutations and gastrointestinal cancers: When to expect the unexpected? 38
Totale 929
Categoria #
all - tutte 5.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 0 0 0 5 14
2020/2021138 9 15 19 0 15 12 10 12 14 12 13 7
2021/202279 5 17 2 1 0 5 1 5 11 10 1 21
2022/2023239 14 34 12 21 16 31 0 7 44 3 46 11
2023/2024143 25 4 11 12 19 41 1 9 0 3 1 17
2024/2025177 28 23 7 7 12 8 14 6 44 23 5 0
Totale 929